Skip to main content
SpringerLink
Log in

Rapid Spreading and Immune Evasion by Vaccinia Virus

  • Conference paper
  • First Online:
Infectious Diseases and Nanomedicine II

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 808))

Abstract

Vaccinia virus (VACV) is the live vaccine that was used to eradicate smallpox, a feat achieved in 1977 and certified by the World Health Organization in 1980. Since 1980, research with VACV has continued in part because of the development of techniques to genetically manipulate VACV and create live VACV strains expressing foreign genes. These recombinant VACVs can be used as live vaccines against other infectious diseases and cancers, and as a powerful tool to study virus pathogenesis, immunology, cell biology, and virus–host interactions. This short article describes two examples of how enduring interest in VACV has revealed new features of VACV biology and the immune system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jenner E (1798) An enquiry into the causes and effects of variolae vaccinae, a disease discovered in some Western Countries of England, particularly Gloucestershire, and known by the name of cowpox. Cassell, London Reprinted by Cassell, 1896

    Google Scholar 

  2. Jenner E (1801) The origin of the vaccine inoculation. D.N. Shury, London

    Google Scholar 

  3. Fenner F, Anderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organisation, Geneva

    Google Scholar 

  4. Baxby D (1981) Jenner’s smallpox vaccine: the riddle of the origin of vaccinia virus. Heinemann, London

    Google Scholar 

  5. Downie AW (1939) Immunological relationship of the virus of spontaneous cowpox to vaccinia virus. Br J Exp Pathol 20:158–176

    Google Scholar 

  6. Panicali D, Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci USA 79:4927–4931

    Article  CAS  Google Scholar 

  7. Mackett M, Smith GL, Moss B (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci USA 79:7415–7419

    Article  CAS  Google Scholar 

  8. Smith GL, Mackett M, Moss B (1983) Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302:490–495

    Article  CAS  Google Scholar 

  9. Smith GL, Murphy BR, Moss B (1983) Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci USA 80:7155–7159

    Article  CAS  Google Scholar 

  10. Panicali D, Davis SW, Weinberg RL, Paoletti E (1983) Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin. Proc Natl Acad Sci USA 80:5364–5368

    Article  CAS  Google Scholar 

  11. Bennink JR, Yewdell JW, Smith GL, Moss B (1986) Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. J Virol 57:786–791

    CAS  Google Scholar 

  12. Osman M, Kubo T, Gill J, Neipel F, Becker M et al (1999) Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J Virol 73:6136–6140

    CAS  Google Scholar 

  13. Yewdell JW, Bennink JR, Smith GL, Moss B (1985) Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci USA 82:1785–1789

    Article  CAS  Google Scholar 

  14. Mackett M, Smith GL (1986) Vaccinia virus expression vectors. J Gen Virol 67:2067–2082

    Article  CAS  Google Scholar 

  15. Lane JM, Ruben FL, Neff JM, Millar JD (1969) Complications of smallpox vaccination, 1968: national surveillance in the United States. N Engl J Med 281:1201–1208

    Article  CAS  Google Scholar 

  16. Roberts KL, Smith GL (2008) Vaccinia virus morphogenesis and dissemination. Trends Microbiol 16:472–479

    Article  CAS  Google Scholar 

  17. Smith GL, Vanderplasschen A, Law M (2002) The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83:2915–2931

    CAS  Google Scholar 

  18. Condit RC, Moussatche N, Traktman P (2006) In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res 66:31–124

    Article  CAS  Google Scholar 

  19. Hollinshead M, Vanderplasschen A, Smith GL, Vaux DJ (1999) Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol 73:1503–1517

    CAS  Google Scholar 

  20. Dales S, Siminovitch L (1961) The development of vaccinia virus in Earle’s L strain cells as examined by electron microscopy. J Biophys Biochem Cytol 10:475–503

    Article  CAS  Google Scholar 

  21. Sanderson CM, Hollinshead M, Smith GL (2000) The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol 81:47–58

    CAS  Google Scholar 

  22. Schmelz M, Sodeik B, Ericsson M, Wolffe EJ, Shida H et al (1994) Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol 68:130–147

    CAS  Google Scholar 

  23. Tooze J, Hollinshead M, Reis B, Radsak K, Kern H (1993) Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur J Cell Biol 60:163–178

    CAS  Google Scholar 

  24. Hollinshead M, Rodger G, Van Eijl H, Law M, Hollinshead R et al (2001) Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol 154:389–402

    Article  CAS  Google Scholar 

  25. Ward BM, Moss B (2001) Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J Virol 75:11651–11663

    Article  CAS  Google Scholar 

  26. Rietdorf J, Ploubidou A, Reckmann I, Holmstrom A, Frischknecht F et al (2001) Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat Cell Biol 3:992–1000

    Article  CAS  Google Scholar 

  27. Geada MM, Galindo I, Lorenzo MM, Perdiguero B, Blasco R (2001) Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J Gen Virol 82:2747–2760

    CAS  Google Scholar 

  28. Cudmore S, Cossart P, Griffiths G, Way M (1995) Actin-based motility of vaccinia virus. Nature 378:636–638

    Article  CAS  Google Scholar 

  29. Stokes GV (1976) High-voltage electron microscope study of the release of vaccinia virus from whole cells. J Virol 18:636–643

    CAS  Google Scholar 

  30. Hiller G, Weber K, Schneider L, Parajsz C, Jungwirth C (1979) Interaction of assembled progeny pox viruses with the cellular cytoskeleton. Virology 98:142–153

    Article  CAS  Google Scholar 

  31. Blasco R, Cole NB, Moss B (1991) Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein. J Virol 65:4598–4608

    CAS  Google Scholar 

  32. Payne LG (1980) Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J Gen Virol 50:89–100

    Article  CAS  Google Scholar 

  33. Appleyard G, Hapel AJ, Boulter EA (1971) An antigenic difference between intracellular and extracellular rabbitpox virus. J Gen Virol 13:9–17

    Article  CAS  Google Scholar 

  34. Law M, Hollinshead R, Smith GL (2002) Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J Gen Virol 83:209–222

    CAS  Google Scholar 

  35. Payne LG (1979) Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J Virol 31:147–155

    CAS  Google Scholar 

  36. Dulbecco R (1952) Production of plaques in monolayer tissue cultures by single particles of an animal virus. Proc Natl Acad Sci USA 38:747–752

    Article  CAS  Google Scholar 

  37. Doceul V, Hollinshead M, van der Linden L, Smith GL (2010) Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327:873–876

    Article  CAS  Google Scholar 

  38. Carter GC, Rodger G, Murphy BJ, Law M, Krauss O et al (2003) Vaccinia virus cores are transported on microtubules. J Gen Virol 84:2443–2458

    Article  CAS  Google Scholar 

  39. Engelstad M, Howard ST, Smith GL (1992) A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188:801–810

    Article  CAS  Google Scholar 

  40. Parkinson JE, Smith GL (1994) Vaccinia virus gene A36R encodes a M(r) 43–50 K protein on the surface of extracellular enveloped virus. Virology 204:376–390

    Article  CAS  Google Scholar 

  41. Roper RL, Wolffe EJ, Weisberg A, Moss B (1998) The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J Virol 72:4192–4204

    CAS  Google Scholar 

  42. Lorenzo MM, Galindo I, Griffiths G, Blasco R (2000) Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. J Virol 74:10535–10550

    Article  CAS  Google Scholar 

  43. Roper RL, Payne LG, Moss B (1996) Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J Virol 70:3753–3762

    CAS  Google Scholar 

  44. Rottger S, Frischknecht F, Reckmann I, Smith GL, Way M (1999) Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J Virol 73:2863–2875

    CAS  Google Scholar 

  45. Sanderson CM, Frischknecht F, Way M, Hollinshead M, Smith GL (1998) Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell–cell fusion. J Gen Virol 79:1415–1425

    CAS  Google Scholar 

  46. van Eijl H, Hollinshead M, Smith GL (2000) The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology 271:26–36

    Article  Google Scholar 

  47. Wolffe EJ, Weisberg AS, Moss B (2001) The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J Virol 75:303–310

    Article  CAS  Google Scholar 

  48. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801

    Article  CAS  Google Scholar 

  49. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449:819–826

    Article  CAS  Google Scholar 

  50. Paludan SR, Bowie AG (2013) Immune sensing of DNA. Immunity 38:855–869

    Article  Google Scholar 

  51. Moss B (2007) Poxviridae: the viruses and their replicaton. In: Knipe DM (ed) Fields virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2905–2946

    Google Scholar 

  52. Fahy AS, Clark RH, Glyde EF, Smith GL (2008) Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol 89:2377–2387

    Article  CAS  Google Scholar 

  53. Peters NE, Ferguson BJ, Mazzon M, Fahy AS, Krysztofinska E et al (2013) A mechanism for the inhibition of DNA-PK-mediated DNA sensing by vaccinia virus. PLoS Pathog 9: e1003649

    Google Scholar 

  54. Ferguson BJ, Mansur DS, Peters NE, Ren H, Smith GL (2012) DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. elife 1: e00047

    Google Scholar 

  55. Gloeckner CJ, Boldt K, Schumacher A, Roepman R, Ueffing M (2007) A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7:4228–4234

    Article  CAS  Google Scholar 

  56. Collis SJ, DeWeese TL, Jeggo PA, Parker AR (2005) The life and death of DNA-PK. Oncogene 24:949–961

    Article  CAS  Google Scholar 

  57. Spagnolo L, Rivera-Calzada A, Pearl LH, Llorca O (2006) Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Mol Cell 22:511–519

    Article  CAS  Google Scholar 

  58. Rivera-Calzada A, Spagnolo L, Pearl LH, Llorca O (2007) Structural model of full-length human Ku70-Ku80 heterodimer and its recognition of DNA and DNA-PKcs. EMBO Rep 8:56–62

    Article  CAS  Google Scholar 

  59. Turner RL (1931) A comparative and etymological dictionary of the Nepali language. Oxford University Press, Oxford

    Google Scholar 

Download references

Acknowledgments

Work in my laboratory has been supported generously by grants from the UK Medical Research Council and the Wellcome Trust, and I thank these funding agencies most warmly for this support. GLS is a Wellcome Trust Principal Research Fellow. I am also deeply grateful to the Nepalese Association of Medical Microbiology for the kind invitation to visit Nepal and speak at this First International Conference on Infectious Diseases and Nanomedicine-2012 (ICIDN-2012). On a personal note, it was a special honor to visit the country of the Gurkhas who were comrades in arms with my grandfather Professor Sir Ralph L Turner MC during the Great War and who saved his life in 1917, in Palestine. In the preface to R.L. Turner’s dictionary of the Nepali language [59] he expressed his lifelong respect and affection for the Gurkha soldier by words that are now engraved on the British Memorial to the Gurkha soldier in Whitehall, London and were unveiled by Her Majesty Queen Elizabeth II in 1997: “Bravest of the brave, most generous of the generous, never had country more faithful friends than you”. To be able to recite these words before the people and President of Nepal was an unforgettable experience.

Author information

Authors and Affiliations

  1. Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK

    Geoffrey L. Smith

Authors
  1. Geoffrey L. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Geoffrey L. Smith .

Editor information

Editors and Affiliations

  1. Central Department of Chemistry, Tribhuvan University, Kathmandu, Nepal

    Rameshwar Adhikari

  2. Department of Microbiology, Tribhuvan University, Kathmandu, Nepal

    Santosh Thapa

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer India

About this paper

Cite this paper

Smith, G.L. (2014). Rapid Spreading and Immune Evasion by Vaccinia Virus. In: Adhikari, R., Thapa, S. (eds) Infectious Diseases and Nanomedicine II. Advances in Experimental Medicine and Biology, vol 808. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1774-9_6

Download citation

Publish with us

Policies and ethics

Search

Navigation